@applehelix.bsky.social
Entrepreneur. Drug hunter. Novice biotech scripophile. Anti-ideologues. Proudly blocked by Vinay Prasad. http://linkedin.com/in/jliang1/
@biotechtv.bsky.social
News, stories, and educational videos about the biotechnology sector. Bringing biotech to life. 📺
@investrclouseau.bsky.social
Not a CFA, biotech investor, still recovering from a decade in neuroscience, so now focusing on drugs that work
@adamfeuerstein.bsky.social
Reporter at STAT. The Harry Kane of biotech. Dog ❤️er. Polk Award winner. Said one analyst: The likes of Adam Feuerstein attack viciously.
@biopharmcatalyst.bsky.social
FDA catalyst calendar, newsletters, and more. We do not provide investment advice or recommendations. #biotech #stocks https://www.biopharmcatalyst.com/
@pdrworld.bsky.social
Biotech exec, pro drug developer. Amateur everything else: COOKING, ferments, preserving, charcuterie, fishing, gardening, weightlifting, BIRDER, photography, physics, literature, writer, history, DAD
@dereklowe.bsky.social
Medicinal chemist / chemical biologist, author of “In the Pipeline” at http://science.org/blogs/pipeline. derekb.lowe@gmail.com and on Signal at Dblowe.18 All opinions are mine; I don’t speak for my employer in any way.
@doudna-lab.bsky.social
News from Jennifer Doudna's lab at UC Berkeley, Innovative Genomics Institute. Tweets from lab members and not Jennifer Doudna unless signed JD. Tweets represent personal views only. doudnalab.org
@franksdavid.bsky.social
Biotech R&D strategy @ Pharmagellan. Prof of Practice of Biotech @ Tufts Biology. Bio, books, blog & more at www.pharmagellan.com. #biosky
@bsky.app
official Bluesky account (check username👆) Bugs, feature requests, feedback: support@bsky.app